Unc13A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Unc13A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
UNC13A (also known as Munc13-1) is a large presynaptic protein essential for synaptic vesicle priming and neurotransmitter release. It plays a critical role in the molecular cascade leading to synaptic vesicle fusion with the presynaptic membrane. UNC13A is encoded by the UNC13A gene, and polymorphisms in this gene are associated with increased risk for amyotrophic lateral sclerosis (ALS), linking synaptic dysfunction to motor neuron degeneration<sup>[1]</sup>.
Structure
UNC13A contains multiple distinct domains:
C1 Domain: Diacylglycerol (DAG) binding domain for phorbol ester activation
C2A Domain: Calcium/phospholipid binding domain
Munc13 Homology Domains (MHD): Required for vesicle priming
Understanding how ALS risk variants affect UNC13A function
Developing therapies to restore synaptic vesicle priming
Biomarkers for synaptic dysfunction in ALS
Links between UNC13A and other ALS genes ([C9orf72](/entities/c9orf72), TDP-43)
Background
The study of Unc13A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.